Tag | Content |
---|
EnhancerAtlas ID | HS139-30402 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr2:153502280-153504300 |
SNPs | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Foxd3 | MA0041.1 | chr2:153502681-153502693 | AAACAAACAAAC | - | 6.32 | GFI1 | MA0038.2 | chr2:153503501-153503513 | TGCAGTGATTGA | - | 6.18 | RREB1 | MA0073.1 | chr2:153502847-153502867 | CCCCCGCCCACCCCCCCAGA | + | 6.61 | SP2 | MA0516.2 | chr2:153502843-153502860 | ACAACCCCCGCCCACCC | + | 6.72 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_04761 | chr2:153503081-153505377 | Brain_Cingulate_Gyrus | SE_06676 | chr2:153502815-153505149 | Brain_Hippocampus_Middle_150 | SE_07714 | chr2:153503670-153505504 | Brain_Inferior_Temporal_Lobe |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 2 | ID | Chromosome | Start | End |
GH02I152646 | chr2 | 153502877 | 153504592 | GH02I152643 | chr2 | 153500219 | 153502346 |
|
Enhancer Sequence | TGTCCTTCCC TTACCCCTGT CTTGGCCTTT GAGTTACTCA GTTAAACCCA TTTTGATCTG 60 AAGCGACTGA AAGCAGGTCC TGGCCAGGTA ACATTACAGC CTTTGAAGGA TTAAGATCTT 120 TAGAACTAAT TGCTCAGAGG ATGAAGAACC ACAAAGCTGC ATATGAGGCA AAAGTGTAAT 180 TCTGGCCTTT CATTACCAGT GTGGGCTAGG AAGCAGAGGC TTGAGAGGAT TGGGGTATGC 240 AAAACTATTT TTTCCTTAAA TTTAAGAGTA GAGGCTGGGC ATAGTGGCTC ACACCTGTAA 300 TCTGTAATCC CAGCACTCTG GGAGGCCGAG GTGGGCAAAT CTGTTGAGTT CAAGATCACC 360 CTGGGCAATG AAGCAAAATC CCCATCTCTA CAAAAAAAAA AAAACAAACA AACAAAGTTA 420 GCCAGGCATG GTGGCAAATG CCTGTAGCCC AGCTACCTGG GACGCTGAGA TGTGTGGATC 480 CCTTGAGCCC AGGAGGTGGA TGCTGCAGTG AGCAGAGATC ACCACTACAC TCGAGCCTCA 540 GTGACAGAGA CTGTCCTCCC CTCACAACCC CCGCCCACCC CCCCAGAAAA GAGTAGGGCA 600 GGGTCACACA AATTCCAATG AGTCAAGGAG CCAGGAAGGT AACAGGCCTG GTAGGAACTG 660 TGCTGAACCT AGAGCACAGA TCTTAGCTCC AACTTCTTTT TGCTGTGTAG GAACTGGGGC 720 CCGGTTTTGC CAGATCTTCC AGTTTTTCAA AAGAAGCCAG AAACCCTGGT CTTTATGTTA 780 ATTACCAATT TAAACACCAG GAAACTGTAC ATGTGCGGGG GGTGGGGGGG CACAGTGGAG 840 CAAACATTCT GTGGGTCAAA TGTGGTCCAT CAGCTGCATT TTCAACTTGT TGAGTAGATA 900 AAGGGATACA AAAGATTCAA TTTGGTTTAA TTCTGTTATT TGTTTGTATT TCCCTTTCTA 960 AAGATAGCAT GTATTCTAGC AGAAGTCAAC AATACTAAGT TAATGAAAGG GAAGTAAATA 1020 CTAATTAAAC AGGAAAAGTA TAAAGCCTGC TTTACTTTTT TCACTATGCC CTGACTTCAT 1080 CAAAGGGAGG CTGCATAGCC TAGCCTGCTG GCTAGCTACC TGACTTACTC AAGAAAGCAT 1140 GCCTTCATAC TGAGTTCTTG TATAAAATTC CTCTGCTCCT CCCACTTCAT CCTGACAGAG 1200 CAATGCCTAT TTGGACTGGT ATGCAGTGAT TGACTCATTC ATTTAACAAG GATTTTCTTA 1260 TGCAGGAGGG CCCACACAAC TACTTCTTGC TGACGTAACA TAAAAAATAT TGGGTGGTAG 1320 AGCTCGGTAG TCCCCACTTC TCAGGAGGCT GAGGTGGGAG AATCGCTTGA GACTGGTTCA 1380 AGTCTGGCCT GGACAACATA ACAAGACCCC ATTTCTTAAA AAAAATAGGT GGCAGAAAAG 1440 GATGCCAGGG AATAGATTAT TATTTTGGTT TAGATTTAAT GGTTAATTGA ACATCATTTT 1500 GTTTAAAATT TACAAAATAA TAAACTCAGC TAGCTTAATG GAATGAAAAT AATAGAGCCC 1560 TTATCTGCAA ACTGAAGGTC TTTAGGTTCT TGTTAAAACT GCGAGGAAAA GATGGGACAG 1620 GACAGTCTGC TTTATTAATT TTGCAGTTTA AAATTTATTG CAGTTACTAT TTATTCATTC 1680 AGGCTTCCAG AATAAAAACA AAACAAAAAA ATTAAGCTAC AGCTGCTTCT AATTTAAGAA 1740 ACATTTCAAA ATAAGACTTC AGCTAGACTC TGGCCAGTGA CAGAAATAAT CTATGTATTT 1800 TTCTCTCAAA GTCCTAGAAT CCTACCAGTA TTACATCCTG TTTTGTTTGA TTGTAAATAT 1860 TGAAGGCAAA TGTTTTATGT CTTTGATTCA ATGCTCAGTG AGTTTGAAGG GCCCATTAGC 1920 TGACTTTTCT ACACAAGCTG CTTTGATTGG CTGCCAGCTG GCCTTTGTCC TGCTTAGACA 1980 CATGCTATTA AAGGTTGCTA TTCTCTCACT GGCACTCTCC 2020
|